lobbying_activities: 2086394

Individual lobbying activities reported in quarterly filings. Each row is one issue area for one client — includes the specific issues lobbied on, government entities contacted, and income/expense amounts.

Data license: Public Domain (U.S. Government data) · Data source: Federal Register API & Regulations.gov API

This data as json

id	filing_uuid	filing_type	registrant_name	registrant_id	client_name	filing_year	filing_period	issue_code	specific_issues	government_entities	income_amount	expense_amount	is_no_activity	is_termination	received_date
2086394	9fb0c37b-72e7-4cfd-8e99-2dbbc8ea7da8	Q4	MERCK & CO, INC.	24908	MERCK & CO INC	2017	fourth_quarter	HCR	340B (no specific bill), Hepatitis C (general education; no specific bill), Vaccine policies (general education; first dollar coverage; preventative services), antimicrobial resistance (general education), biosimilars (no specific bill), cost and value of medicines (no specific bill), women's health (general education), Affordable Care Act, general pharmaceutical issues (transparency, formulary design, prescription drug coverage), Implementation of P.L.114-255 - 21st Century Cures Act; PAHPA (Pandemic and All Hazards Preparedness Act)	Centers For Medicare and Medicaid Services (CMS),HOUSE OF REPRESENTATIVES,SENATE		790000	0	0	2018-01-22T15:03:17.873000-05:00